Two-week Intensive Outpatient Trauma Treatment.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorOslo University Hospital

About this trial

The objective of the study is to obtain knowledge about the treatment of patients who are offered intensive trauma treatment at Nydalen DPS (NDPS) and Søndre Oslo DPS (SODPS). The treatment takes place on an outpatient basis over two weeks. Up to 42 patients will be recruited. The efficacy of treatment will be investigated using validated self-report forms, which measure PTSD symptoms (PCL-5 and ITQ) and quality of life/function (WHO-5, and WSAS). The measurements will be done before the treatment and one and twelve weeks after treatment.In-depth interviews will also be conducted with up to 30 patients to investigate the outcome and any need for adjustments with focus on patients with minority backgrounds, men and patients with limited benefit. The study uses a mixed methods design, where quantitative measures and information from qualitative interviews are combined to map participants' experience, benefits and feasibility.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

PTSD

18-65 years

Able to give written informed consent.

Disqualifiers

Active substance abuse

psychotic or bipolar disorder

organic brain disorder

IQ< 70

Trial design

Design model

Single group

Treatments tested in this trial

  • Prolonged exposure and EMDR

    Other intervention

    Two-week intensive traume treatment

Treatment groups

42 Participants
are divided into 1 treatment group
Group A: Intensive trauma treatmentExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Trauma symptom score as measured by International Trauma Questionnaire (ITQ)

ITQ: Higher score equals higher symptom load

Time frame
12 weeks

Secondary outcomes

1

Function as measured by Work and social adjustment scale (WSAS)

Higher scores equals poorer function

Time frame
12 weeeks

Other outcomes

1

Quality of life as measured by WHO-5, PTSD symptom load as measured by PCL-5

Higher scores on WHO-5 equals better QoL, Higher scores on PCL-5 equal more PTSD symptoms

Time frame
12 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.